Orthologous metabonomic qualification of a rodent model combined with magnetic resonance imaging for an integrated evaluation of the toxicity of Hypochoeris radicata

Chemical Research in Toxicology

Volumn 21, Issue 11, 2008, Pages 2082-2096

  Domange, Céline ^a   Canlet, Cécile ^a   Traoré, Amidou ^b   Biélicki, Guy ^b   Keller, Cécile ^b   Paris, Alain ^a   Priymenko, Nathalie ^a,c  

^a CNRS   (France)

^b CEMAGREF   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN EXTRACT; CHOLINE; INOSITOL DERIVATIVE; LACTIC ACID; LIVER EXTRACT; N ACETYLASPARTIC ACID; SCYLLOINOSITOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC IMAGING; EXPERIMENTAL ANIMAL; FEMALE; GLIA CELL; HYPOCHOERIS RADICATA; INFLORESCENCE; INTOXICATION; LIVER METABOLISM; MALE; METABOLITE; METABONOMIC; MOLECULAR BIOLOGY; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYTOTOXICITY; PLANT; TARGET ORGAN; THALAMUS; URINE;

ANIMALS; ASTERACEAE; BIOLOGICAL MARKERS; BRAIN; FEMALE; INOSITOL; LIVER; MAGNETIC RESONANCE IMAGING; MALE; METABOLOMICS; MICE; MICE, INBRED C57BL; PLANT POISONING;

ANIMALIA; EQUIDAE; HYPOCHAERIS RADICATA; RODENTIA;

EID: 57449100445     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx800159x     Document Type: Article

References (75)

1. Nicholson, J. K., Lindon, J. C., and Holmes, E. (1999) 'Metabonomics': Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189.
2. Nicholson, J. K., Connelly, J., Lindon, J. C., and Holmes, E. (2002) Metabonomics: A platform for studying drug toxicity and gene function. Nat. Rev. Drug Discovery 1, 153-161.
3. Gavaghan, C. L., Holmes, E., Lenz, E., Wilson, I. D., and Nicholson, J. K. (2000) An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: Application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett. 484, 169-174.
4. Gavaghan, C. L., Wilson, I. D., and Nicholson, J. K. (2002) Physiological variation in metabolic phenotyping and functional genomic studies: Use of orthogonal signal correction and PLS-DA. FEBS Lett. 530, 191-196.
5. Slocombe, R. F., Huntington, P. J., Friend, S. C., Jeffcott, L. B., Luff, A. R., and Finkelstein, D. K. (1992) Pathological aspects of Australian Stringhalt. Equine Vet. J. 24, 174-183.
6. Huntington, P. J., Jeffcott, L. B., Friend, S. C., Luff, A. R., Finkelstein, D. I., and Flynn, R. J. (1989) Australian Stringhalt - Epidemiological, clinical and neurological investigations. Equine Vet. J. 21, 266-273.
7. Araya, O., Krause, A., and Solis de Ovando, M. (1998) Outbreaks of stringhalt in southern Chile. Vet. Rec. 142, 462-463.
8. Gay, C. C., Fransen, S., Richards, J., and Holler, S. (1993) Hypochoeris-associated stringhalt in North America. Equine Vet. J. 25, 456-457.
9. Gardner, S. Y., Cook, A. G., Jortner, B. S., Troan, B. V., Sharp, N. J. H., Campbell, N. B., and Brownie, C. F. (2005) Stringhalt associated with a pasture infested with Hypochoeris radicata. Equine Vet. Educ. 17, 118-122.
10. Gouy, I., Egron, G., Leblond, A., and Cadoré, J. L. (2005) Study of Australian Harper disease after an outbreak in the Lyon area. Prat. Vét. Equine 37, 53-60.
11. Cahill, J. I., and Goulden, B. E. (1992) Stringhalt-current thoughts on aetiology and pathogenesis. Equine Vet. J. 24, 161-162.
12. Lindon, J. C., Holmes, E., and Nicholson, J. K. (2003) So what's the deal with metabonomics? Anal. Chem. 75, 384A-391A.
13. Holmes, E., Tsang, T. M., and Tabrizi, S. J. (2006) The application of NMR-based metabonomics in neurological disorders. NeuroRx 3, 358-372.
14. Hodavance, M. S., Ralston, S. L., and Pelczer, I. (2007) Beyond blood sugar: the potential of NMR-based metabonomics for type 2 human diabetes, and the horse as a possible model. Anal. Bioanal. Chem 387, 533-537.
15. 1H-NMR-based metabonomics. Nat. Med. 8, 1439-1444.
16. Folch, J., Ascoli, I., Lees, M., Meath, J. A., and Le, B. N. (1951) Preparation of lipide extracts from brain tissue. J. Biol. Chem. 191, 833-841.
17. Waters, N. J., Holmes, E., Waterfield, C. J., Farrant, R. D., and Nicholson, J. K. (2002) NMR and pattern recognition studies on liver extracts and intact livers from rats treated with [alpha]-naphthylisothiocyanate. Biochem. Pharmacol. 64, 67-77.
18. Dumas, M. E., Canlet, C., Andre, F., Vercauteren, J., and Paris, A. (2002) Metabonomic assessment of physiological disruptions using 1H 13C HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables. Anal. Chem. 74, 2261-2273.
19. 1H NMR spectroscopy of ratbrain at 1 ms echo time. Magn. Reson. Med. 41, 649-656.
20. Cahill, J. I., Goulden, B. E., and Jolly, R. D. (1986) Stringhalt in horses: a distal axonopathy. Neuropathol. Appl. Neurobiol. 12, 459-475.
21. Stanley, E. G., Bailey, N. J., Bollard, M. E., Haselden, J. N., Waterfield, C. J., Holmes, E., and Nicholson, J. K. (2005) Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic- resonance-based metabonomics. Anal. Biochem. 343, 195-202.
22. Ruzafa, C., Monserrat, F., Cremades, A., and Penafiel, R. (2003) Influence of dietary arginine on sexual dimorphism of arginine metabolism in mice. J. Nutr. Biochem. 14, 333-341.
23. Dumas, M. E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., and Nicholson, J. K. (2006) Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U.S.A. 103, 12511-12516.
24. Gavaghan, C. L., Holmes, E., Lenz, E., Wilson, I. D., and Nicholson, J. K. (2000) An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: Application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett. 484, 169-174.
25. Heilig, C. W., Stromski, M. E., and Gullans, S. R. (1989) Methylamine and polyol responses to salt loading in renal inner medulla. Am. J. Physiol. 257, F1117-F1123.
26. Dieterle, F., Schlotterbeck, G., Binder, M., Ross, A., Suter, L., and Senn, H. (2007) Application of metabonomics in a comparative profiling study reveals N-acetylfelinine excretion as a biomarker for inhibition of the farnesyl pathway by bisphosphonates. Chem. Res. Toxicol. 20, 1291-1299.
27. Nicholls, A. W., Mortishire-Smith, R. J., and Nicholson, J. K. (2003) NMR spectroscopic-based metabonomic studies of urinary metabolite variation in acclimatizing germ-free rats. Chem. Res. Toxicol. 16, 1395-1404.
28. Wang, Y., Holmes, E., Nicholson, J. K., Cloarec, O., Chollet, J., Tanner, M., Singer, B. H., and Utzinger, J. (2004) Metabonomic investigations in mice infected with Schistosoma mansoni: An approach for biomarker identification. Proc. Natl. Acad. Sci. U.S.A. 101, 12676-12681.
29. Phipps, A. N., Stewart, J., Wright, B., and Wilson, I. D. (1998) Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica 28, 527-537.
30. 1H NMR and HPLC-TOF MS. Mol. Biosyst. 1, 166-175.
31. 1H NMR data sets. Anal. Chem. 77, 1282-1289.
32. 1H-NMR spectroscopy of mouse urine. Biol. Pharm. Bull. 30, 667-670.
33. Pfeuffer, J., Tkac, I., Provencher, S. W., and Gruetter, R. (1999) Toward an in vivo neurochemical profile: Quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the ratbrain. J. Magn. Reson. 141, 104-120.
34. Fleury, P. F., Courtois, J. E., and Jouannet, A.L. (1951) Présence de scyllitol et autres alcools cycliques polyhydriques dans les urines. Bull. Soc. Chim. Biol. (Paris) 33, 1885-1893.
35. Helleu, C. (1957) Elimination urinaire du mésoinositol en relation avec le système digestif. Bull. Soc. Chim. Biol. (Paris) 39, 633-640.
36. Roth, M. E., Cosgrove, K. P., and Carroll, M. E. (2004) Sex differences in the vulnerability to drug abuse: A review of preclinical studies. Neurosci. Biobehav. Rev. 28, 533-546.
37. Valle, A., Guevara, R., Garcia-Palmer, F. J., Roca, P., and Oliver, J. (2007) Sexual dimorphism in liver mitochondrial oxidative capacity is conserved under caloric restriction conditions. Am. J. Physiol. Cell Physiol. 293, C1302-1308.
38. Sherman, W. R., Stewart, M. A., Simpson, P. C., and Goodwin, S. L. (1968) The identification of myo-inosose-2 and scyllo-inositol in mammalian tissues. Biochemistry 7, 819-824.
39. Sherman, W. R., Stewart, M. A., Kurien, M. M., and Goodwin, S. L. (1968) The measurement of myo-inositol, myo-inosose-2 and scyllo-inositol in mammalian tissues. Biochim. Biophys. Acta 158, 197-205.
40. Fisher, S. K., Novak, J. E., and Agranoff, B. W. (2002) Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance. J. Neurochem. 82, 736-754.
41. Fenili, D., Brown, M., Rappaport, R., and McLaurin, J. (2007) Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology. J. Mol. Med. 85, 603-611.
42. Viola, A., Nicoli, F., Denis, B., Confort-Gouny, S., Le Fur, Y., Ranjeva, J. P., Viout, P., and Cozzone, P. J. (2004) High cerebral scyllo-inositol: A new marker of brain metabolism disturbances induced by chronic alcoholism. Magma 17, 47-61.
43. Griffith, H. R., den Hollander, J. A., Stewart, C. C., Evanochko, W. T., Buchthal, S. D., Harrell, L. E., Zamrini, E. Y., Brockington, J. C., and Marson, D. C. (2007) Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease. NMR Biomed. 20, 709-716.
44. Lodi, R., Setola, E., Tonon, C., Ambrosetto, P., Franceschi, E., Crino, L., Barbiroli, B., and Cortelli, P. (2003) Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to Temozolomide administration. Magn. Reson. Imaging 21, 1003-1007.
45. Moore, C. M., Breeze, J. L., Kukes, T. J., Rose, S. L., Dager, S. R., Cohen, B. M., and Renshaw, P. F. (1999) Effects of myo-inositol ingestion on human brain myo-inositol levels: A proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry 45, 1197-1202.
46. Litsky, M. L., Hohl, C. M., Lucas, J. H., and Jurkowitz, M. S. (1999) Inosine and guanosine preserve neuronal and glial cell viability in mouse spinal cord cultures during chemical hypoxia. Brain Res. 821, 426-432.
47. Hsiao, G., Lin, K. H., Chang, Y., Chen, T. L., Tzu, N. H., Chou, D. S., and Sheu, J. R. (2005) Protective mechanisms of inosine in platelet activation and cerebral ischemic damage. Arterioscler., Thromb., Vasc. Biol. 25, 1998-2004.
48. Yang, J. H., Luo, X., Nie, Y., Su, Y., Zhao, Q., Kabir, K., Zhang, D., and Rabinovici, R. (2003) Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology 109, 15-23.
49. Ross, B., and Bluml, S. (2001) Magnetic resonance spectroscopy of the human brain. Anat. Rec. 265, 54-84.
50. 31P magnetic resonance spectroscopy reveals osmotic and metabolic disturbances in human hepatic encephalopathy. J. Neurochem. 71, 1564-1576.
51. Khandelwal, P., Beyer, C. E., Lin, Q., Schechter, L. E., and Bach, A. C. (2004) Studying rat brain neurochemistry using nanoprobe NMR spectroscopy: A metabonomics approach. Anal. Chem. 76, 4123-4127.
52. Kitada, K., Akimitsu, T., Shigematsu, Y., Kondo, A., Maihara, T., Yokoi, N., Kuramoto, T., Sasa, M., and Serikawa, T. (2000) Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system. J. Neurochem. 74, 2512-2519.
53. Chung, Y. L., Barr, J., Bhakoo, K., Williams, S. C., Bell, J. D., and Fraser, J. R. (2003) N-Acetyl aspartate estimation: A potential method for determining neuronal loss in the transmissible spongiform encephalopathies. Neuropathol. Appl. Neurobiol. 29, 445-450.
54. Moffett, J. R., Ross, B., Arun, P., Madhavarao, C. N., and Namboodiri, A. M. (2007) N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology. Prog. Neurobiol. 81, 89-131.
55. 1H NMR spectroscopy in Canavan's disease: A report of two cases. Magn. Reson. Med. 19, 439-445.
56. Grodd, W., Krageloh-Mann, I., Petersen, D., Trefz, F. K., and Harzer, K. (1990) In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 336, 437-438.
57. Robertson-Smith, R. G., Jeffcott, L. B., Friend, S. C., and Badcoe, L. M. (1985) An unusual incidence of neurological disease affecting horses during a drought. Aust. Vet. J. 62, 6-12.
58. Scott, H. L., Pow, D. V., Tannenberg, A. E., and Dodd, P. R. (2002) Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J. Neurosci. 22, RC206.
59. Kirvell, S. L., Esiri, M., and Francis, P. T. (2006) Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease. J. Neurochem. 98, 939-950.
60. Moussa, C. E., Rusnak, M., Hailu, A., Sidhu, A., and Fricke, S. T. (2008) Alterations of striatal glutamate transmission in rotenone-treated mice: MRI/MRS in vivo studies. Exp. Neurol. 209, 224-233.
61. Danbolt, N. C. (2001) Glutamate uptake. Prog. Neurobiol. 65, 1-105.
62. 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease. J. Biol. Chem. 280, 42508-42514.
63. Ross, A. J., and Sachdev, P. S. (2004) Magnetic resonance spectroscopy in cognitive research. Brain Res. Brain Res. Rev. 44, 83-102.
64. Roser, W., Hagberg, G., Mader, I., Brunnschweiler, H., Radue, E. W., Seelig, J., and Kappos, L. (1995) Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn. Reson. Med. 33, 811-817.
65. Davie, C. A., Hawkins, C. P., Barker, G. J., Brennan, A., Tofts, P. S., Miller, D. H., and McDonald, W. I. (1994) Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 117 (Part 1), 49-58.
66. Tartaglia, M. C., Narayanan, S., De Stefano, N., Arnaoutelis, R., Antel, S. B., Francis, S. J., Santos, A. C., Lapierre, Y., and Arnold, D. L. (2002) Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J. Neurol. 249, 1382-1390.
67. Brenner, R. E., Munro, P. M., Williams, S. C., Bell, J. D., Barker, G. J., Hawkins, C. P., Landon, D. N., and McDonald, W. I. (1993) The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio. Magn. Reson. Med. 29, 737-745.
68. MacKay, S., Meyerhoff, D. J., Constans, J. M., Norman, D., Fein, G., and Weiner, M. W. (1996) Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch. Neurol. 53, 167-174.
69. Kaiser, E., Chiba, P., and Zaky, K. (1990) Phospholipases in biology and medicine. Clin. Biochem. 23, 349-370.
70. 1H magnetic resonance and neuropsychological study. J. Neurol. Sci. 160, 148-157.
71. Hirano, F., Tanaka, H., Okamoto, K., Makino, Y., Inaba, M., Nomura, Y., Fukawa, E., Miura, T., Tani, T., and Makino, I. (1995) Natural course of diabetic peripheral neuropathy in spontaneous-onset diabetic Chinese hamsters. Diabetes Res. Clin. Pract. 28, 151-159.
72. Shetty, H. U., Holloway, H. W., and Schapiro, M. B. (1996) Cerebrospinal fluid and plasma distribution of myo-inositol and other polyols in Alzheimer disease. Clin. Chem. 42, 298-302.
73. Atack, J. R., and Schapiro, M. B. (2002) Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF. Neurobiol. Aging 23, 389-396.
74. Barkai, A. I., Dunner, D. L., Gross, H. A., Mayo, P., and Fieve, R. R. (1978) Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol. Psychiatry 13, 65-72.
75. Shimon, H., Agam, G., Belmaker, R. H., Hyde, T. M., and Kleinman, J. E. (1997) Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am. J. Psychiatry 154, 1148-1150.